Beyond Biotech - the podcast from Labiotech Humacyte: Saving lives with lab-grown blood vessels in conflict zones
Trauma surgeons in Ukraine operating theaters saved lives and limbs thanks to the innovative lab-grown blood vessels from US biotech, Humacyte.
Humacyte is pioneering a platform that enables the investigation, development, and manufacture of bioengineered human tissues and organs that are designed to be universally implantable, off-the-shelf, and regenerative, with the goal of treating a wide variety of diseases, injuries, and chronic conditions.
This week I had the chance to speak to Humacyte founder, President and Chief Executive Laura Niklason about the company she has built, the science she is driving forward, and the real-world applications for Humacyte’s lab-grown blood vessels in some of the most devastating and dangerous conflicts.
1:00 Introducing Laura Niklason
4:50 Humacyte and its mission
6:27 Competitive landscape
7:45 Partnering for scale
9:49 How to grow blood vessels in the lab
11:47 Implanting the vessels
13:32 Human vessels vs synthetic vessels
15:10 The manufacturing process
16:23 Overcoming skepticism, demonstrating value
19:01 Navigating the regulatory approval process
21:17 The role of the Department of Defense in innovative biotech
22:30 Using Humacyte vessels in the field
23:20 Humacyte vessels in the Ukraine War
28:22 Lessons from the Ukraine War
30:09 Goals for the coming years
33:35 Scaling manufacturing
Interested in being a sponsor of an episode of our podcast? Discover how you can get involved here!
Stay updated by subscribing to our newsletter
To dive deeper into the topic: